To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Nasopharyngeal carcinoma (NPC) occurs at a high frequency in southern China, northern Africa, and Alaska, with a reported incidence of 30 cases per 100 000 in Guangdong Province. Endoscopic examination and biopsy are the main methods used for detection and diagnosis of NPC. Early NPC patients achieve favourable prognoses after concurrent radiotherapy and chemotherapy in compassion with advanced NPC patients. Here, the investigators focused on the utility of artificial intelligence to detect early NPC, which based on white light imaging (WLI) and Narrow-band imaging (NBI) nasoendoscopic examination. Having access to this unique population provides an unprecedented opportunity to investigate the effect of intelligent system on diverse nasopharyngeal lesions detection and develop a novel Computer-Aided Diagnosis System.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Older than 18 years of age

Locations
Other Locations
China
First Affiliated Hospital of Sun Yat-sen University
RECRUITING
Guangzhou
Sun Yat-Sen University Cancer Center
RECRUITING
Guangzhou
Kiang Wu Hospital
RECRUITING
Macao
Contact Information
Primary
Yihui Wen, Ph.D
wenyihui@mail.sysu.edu.cn
+86-13480200660
Backup
Rui He, M.D.
herui27@mail2.sysu.edu.cn
13096385286
Time Frame
Start Date: 2020-06-20
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 1000
Treatments
NPC group
Patients pathologically diagnosed as NPC by agreement of 2 experienced pathologists who were blinded to the corresponding endoscopic assessment.
Non-NPC group
Patients pathologically diagnosed as non-NPC (including inflammatory hyperplasia, Atypical hyperplasia, Papilloma etc.) by agreement of 2 experienced pathologists who were blinded to the corresponding endoscopic assessment.
Related Therapeutic Areas
Sponsors
Leads: First Affiliated Hospital, Sun Yat-Sen University
Collaborators: Sun Yat-sen University

This content was sourced from clinicaltrials.gov